MedPath
HSA Approval

APO-MOMETASONE AQUEOUS NASAL SPRAY 50MCG/METERED SPRAY

SIN15323P

APO-MOMETASONE AQUEOUS NASAL SPRAY 50MCG/METERED SPRAY

APO-MOMETASONE AQUEOUS NASAL SPRAY 50MCG/METERED SPRAY

August 22, 2017

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SPRAY, METERED

NASAL

Medical Information

R01AD09

mometasone

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

Apotex Inc. (Richmond Hill)

Active Ingredients

Mometasone Furoate (Micronized)

50 mcg/metered spray

Mometasone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-MOMETASONE AQUEOUS NASAL SPRAY 50MCG/METERED SPRAY - HSA Approval | MedPath